Nyxoah SA
NYXH- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001857190
No open-market purchases or sales by Nyxoah SA insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $37.5M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Nyxoah SA as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −2 vs. Q2 2022
- Shares held
- 2.86M
- −148.6K (−4.9%) vs. Q2 2022
- Total value
- $18.1M
- −$10.0M (−35.7%) vs. Q2 2022
- New holders
- 2
- 3 more added
- Sold out
- 4
- 7 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NYXH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $37.5M |
| Q1 2026 | 34 | $10.4M |
| Q4 2025 | 33 | $16.8M |
| Q3 2025 | 32 | $13.5M |
| Q2 2025 | 31 | $29.2M |
| Q1 2025 | 26 | $41.8M |
| Q4 2024 | 22 | $54.4M |
| Q3 2024 | 20 | $39.1M |
| Q2 2024 | 21 | $29.4M |
| Q1 2024 | 19 | $29.3M |
| Q4 2023 | 16 | $9.76M |
| Q3 2023 | 17 | $18.2M |
| Q2 2023 | 16 | $21.1M |
| Q1 2023 | 18 | $17.6M |
| Q4 2022 | 18 | $13.3M |
| Q3 2022 | 20 | $18.1M |
| Q2 2022 | 22 | $28.1M |
| Q1 2022 | 18 | $59.1M |
| Q4 2021 | 16 | $60.9M |
| Q3 2021 | 18 | $75.1M |
| Q2 2021 | 1 | $5.75M |
| Q1 2021 | 1 | $7.18M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Nyxoah SA; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 653,547 | $4.12M | 0.00% | −5,723−0.9% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 455,262 | $2.87M | 0.06% | 00.0% | Unchanged |
| Invesco Ltd. | 381,529 | $2.40M | 0.00% | −25,733−6.3% | Reduced |
| RTW Investments, LP | 344,911 | $2.17M | 0.05% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 221,949 | $1.42M | 0.21% | 00.0% | Unchanged |
| AXA S.A. | 200,000 | $1.26M | 0.00% | +13,800+7.4% | Added |
| Putnam Investments LLC | 192,942 | $1.22M | 0.00% | 00.0% | Unchanged |
| Rossmore Private Capital | 117,940 | $762.0K | 0.14% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 79,021 | $498.0K | 0.58% | −11,976−13.2% | Reduced |
| Evolutionary Tree Capital Management, LLC | 54,345 | $342.0K | 0.33% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 50,382 | $317.0K | 0.00% | +50,382 | New |
| DekaBank Deutsche Girozentrale | 33,200 | $213.0K | 0.00% | 00.0% | Unchanged |
| Banque Cantonale Vaudoise | 30,000 | $194.0K | 0.01% | +18,000+150.0% | Added |
| Gilder Gagnon Howe & Co LLC | 29,472 | $186.0K | 0.00% | −353−1.2% | Reduced |
| Sio Capital Management, LLC | 16,110 | $101.0K | 0.04% | 00.0% | Unchanged |
| Citigroup Inc | 412 | $3.00K | 0.00% | +206+100.0% | Added |
| Tower Research Capital LLC (TRC) | 300 | $2.00K | 0.00% | +300 | New |
| Barclays PLC | 120 | $1.00K | 0.00% | −114−48.7% | Reduced |
| UBS Group AG | 64 | $0 | 0.00% | −1,335−95.4% | Reduced |
| Wells Fargo & Company | 17 | $0 | 0.00% | −330−95.1% | Reduced |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −127,903−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −27,904−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −26,423−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −3,444−100.0% | Sold out |